Ubs Oconnor LLC Merck & Co., Inc. Transaction History

Ubs Oconnor LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$108.61 - $118.38 $628,851 - $685,420	5,790 New	5,790 $668 Million
Q1 2023 May 15, 2023	BUY	$102.94 - $114.86 $1.47 Million - $1.64 Million	14,303 Added 401.66%	17,864 $1.9 Million
Q4 2022 Feb 14, 2023	SELL	$87.44 - $112.11 $1.68 Million - $2.16 Million	-19,239 Reduced 84.38%	3,561 $0
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $1.93 Million - $2.17 Million	22,800 New	22,800 $1.96 Billion
Q2 2017 Aug 14, 2017	BUY	N/A	42,252	42,252 $0

3,820

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

Stay updated on Ubs Oconnor LLC with notifications on news.